NEWTON, MA, USA I December 09, 2024 I Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and inhibiting the oncogenic cell states of ...
CCR2 was highly expressed on malignant monocytes from AML patient samples, with cases of acute monocytic leukemia (M5) and acute myelomonocytic leukemia (M4), showing the highest levels of expression.
The patient denied any systemic symptoms, preceding illnesses, weight loss, loss of appetite, or fevers. Her medical history included immunohistochemical staining for CD68PG highlighted cells of ...